Logo image of PED

PEDEVCO CORP (PED) Stock Fundamental Analysis

USA - NYSEARCA:PED - US70532Y3036 - Common Stock

0.577 USD
+0.01 (+2%)
Last: 11/7/2025, 8:07:39 PM
Fundamental Rating

5

Overall PED gets a fundamental rating of 5 out of 10. We evaluated PED against 210 industry peers in the Oil, Gas & Consumable Fuels industry. PED has only an average score on both its financial health and profitability. PED is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year PED was profitable.
PED had a positive operating cash flow in the past year.
In multiple years PED reported negative net income over the last 5 years.
In the past 5 years PED always reported a positive cash flow from operatings.
PED Yearly Net Income VS EBIT VS OCF VS FCFPED Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

PED's Return On Assets of 9.35% is amongst the best of the industry. PED outperforms 84.76% of its industry peers.
The Return On Equity of PED (10.61%) is better than 63.33% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.35%, PED is doing worse than 73.81% of the companies in the same industry.
PED had an Average Return On Invested Capital over the past 3 years of 3.09%. This is significantly below the industry average of 21.78%.
Industry RankSector Rank
ROA 9.35%
ROE 10.61%
ROIC 0.35%
ROA(3y)5.71%
ROA(5y)-5.05%
ROE(3y)6.44%
ROE(5y)-5.07%
ROIC(3y)3.09%
ROIC(5y)N/A
PED Yearly ROA, ROE, ROICPED Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800

1.3 Margins

PED's Profit Margin of 36.22% is amongst the best of the industry. PED outperforms 90.95% of its industry peers.
PED's Operating Margin of 1.57% is on the low side compared to the rest of the industry. PED is outperformed by 71.90% of its industry peers.
Looking at the Gross Margin, with a value of 64.39%, PED is in the better half of the industry, outperforming 72.38% of the companies in the same industry.
In the last couple of years the Gross Margin of PED has grown nicely.
Industry RankSector Rank
OM 1.57%
PM (TTM) 36.22%
GM 64.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.09%
GM growth 5Y7.61%
PED Yearly Profit, Operating, Gross MarginsPED Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K -1K

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PED is destroying value.
Compared to 1 year ago, PED has more shares outstanding
PED has more shares outstanding than it did 5 years ago.
PED has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PED Yearly Shares OutstandingPED Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
PED Yearly Total Debt VS Total AssetsPED Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

PED has an Altman-Z score of 1.16. This is a bad value and indicates that PED is not financially healthy and even has some risk of bankruptcy.
PED has a Altman-Z score (1.16) which is in line with its industry peers.
There is no outstanding debt for PED. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.16
ROIC/WACC0.04
WACC8.75%
PED Yearly LT Debt VS Equity VS FCFPED Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

PED has a Current Ratio of 1.67. This is a normal value and indicates that PED is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of PED (1.67) is better than 71.43% of its industry peers.
PED has a Quick Ratio of 1.67. This is a normal value and indicates that PED is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.67, PED is doing good in the industry, outperforming 74.76% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 1.67
PED Yearly Current Assets VS Current LiabilitesPED Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

4

3. Growth

3.1 Past

PED shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 188.00%, which is quite impressive.
Looking at the last year, PED shows a small growth in Revenue. The Revenue has grown by 3.93% in the last year.
PED shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.98% yearly.
EPS 1Y (TTM)188%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-166.67%
Revenue 1Y (TTM)3.93%
Revenue growth 3Y35.61%
Revenue growth 5Y24.98%
Sales Q2Q%-40.97%

3.2 Future

The Earnings Per Share is expected to decrease by -36.44% on average over the next years. This is quite bad
The Revenue is expected to decrease by -0.26% on average over the next years.
EPS Next Y-69.7%
EPS Next 2Y-36.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-15.27%
Revenue Next 2Y-0.26%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PED Yearly Revenue VS EstimatesPED Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
PED Yearly EPS VS EstimatesPED Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2021 2022 2023 2024 2025 2026 0 -2 -4 -6

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 4.12, the valuation of PED can be described as very cheap.
Based on the Price/Earnings ratio, PED is valued cheaper than 95.71% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 25.83. PED is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 7.14, the valuation of PED can be described as very cheap.
PED's Price/Forward Earnings ratio is rather cheap when compared to the industry. PED is cheaper than 89.05% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 32.68, PED is valued rather cheaply.
Industry RankSector Rank
PE 4.12
Fwd PE 7.14
PED Price Earnings VS Forward Price EarningsPED Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

90.95% of the companies in the same industry are more expensive than PED, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.71
PED Per share dataPED EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

A cheap valuation may be justified as PED's earnings are expected to decrease with -36.44% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-36.44%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

PED does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PEDEVCO CORP

NYSEARCA:PED (11/7/2025, 8:07:39 PM)

0.577

+0.01 (+2%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-14 2025-08-14/amc
Earnings (Next)11-17 2025-11-17
Inst Owners2.45%
Inst Owner Change0%
Ins Owners71.93%
Ins Owner Change1.92%
Market Cap53.07M
Revenue(TTM)35.33M
Net Income(TTM)12.80M
Analysts80
Price Target1.53 (165.16%)
Short Float %0.14%
Short Ratio0.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-16.92%
Min Revenue beat(2)-28.89%
Max Revenue beat(2)-4.95%
Revenue beat(4)2
Avg Revenue beat(4)-5%
Min Revenue beat(4)-28.89%
Max Revenue beat(4)12.69%
Revenue beat(8)5
Avg Revenue beat(8)1.96%
Revenue beat(12)6
Avg Revenue beat(12)1.3%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-17.81%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 4.12
Fwd PE 7.14
P/S 1.5
P/FCF N/A
P/OCF 2.95
P/B 0.44
P/tB 0.44
EV/EBITDA 2.71
EPS(TTM)0.14
EY24.26%
EPS(NY)0.08
Fwd EY14%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.2
OCFY33.88%
SpS0.38
BVpS1.31
TBVpS1.31
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.03
Profitability
Industry RankSector Rank
ROA 9.35%
ROE 10.61%
ROCE 0.44%
ROIC 0.35%
ROICexc 0.37%
ROICexgc 0.37%
OM 1.57%
PM (TTM) 36.22%
GM 64.39%
FCFM N/A
ROA(3y)5.71%
ROA(5y)-5.05%
ROE(3y)6.44%
ROE(5y)-5.07%
ROIC(3y)3.09%
ROIC(5y)N/A
ROICexc(3y)3.72%
ROICexc(5y)N/A
ROICexgc(3y)3.72%
ROICexgc(5y)N/A
ROCE(3y)3.91%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.09%
GM growth 5Y7.61%
F-Score5
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 124.67%
Cap/Sales 54.78%
Interest Coverage 250
Cash Conversion 111.8%
Profit Quality N/A
Current Ratio 1.67
Quick Ratio 1.67
Altman-Z 1.16
F-Score5
WACC8.75%
ROIC/WACC0.04
Cap/Depr(3y)201.19%
Cap/Depr(5y)159.31%
Cap/Sales(3y)75.11%
Cap/Sales(5y)87.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)188%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-166.67%
EPS Next Y-69.7%
EPS Next 2Y-36.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.93%
Revenue growth 3Y35.61%
Revenue growth 5Y24.98%
Sales Q2Q%-40.97%
Revenue Next Year-15.27%
Revenue Next 2Y-0.26%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-86.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year183.34%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y86.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.41%
OCF growth 3Y28.83%
OCF growth 5Y50.2%

PEDEVCO CORP / PED FAQ

What is the fundamental rating for PED stock?

ChartMill assigns a fundamental rating of 5 / 10 to PED.


Can you provide the valuation status for PEDEVCO CORP?

ChartMill assigns a valuation rating of 6 / 10 to PEDEVCO CORP (PED). This can be considered as Fairly Valued.


What is the profitability of PED stock?

PEDEVCO CORP (PED) has a profitability rating of 5 / 10.


What are the PE and PB ratios of PEDEVCO CORP (PED) stock?

The Price/Earnings (PE) ratio for PEDEVCO CORP (PED) is 4.12 and the Price/Book (PB) ratio is 0.44.


What is the expected EPS growth for PEDEVCO CORP (PED) stock?

The Earnings per Share (EPS) of PEDEVCO CORP (PED) is expected to decline by -69.7% in the next year.